Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

Mesh-covered carotid stent associated with low 30-day stroke rates

Patients treated for carotid stenosis with a new mesh-covered stent demonstrated stroke rates of 1.1 percent at 30 days, suggesting the device could help overcome one of the previously reported weaknesses of carotid artery stenting.

Arizona patients successfully receive the world’s first bioconvertible IVC filter commercially offered in US

BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter.

Risk calculator predicts mortality for PAD patients using EHR data

An automated risk calculator derived solely from variables in an electronic health record (EHR) accurately predicted five-year survival in a community-based cohort of patients with peripheral artery disease (PAD), researchers reported Dec. 1 in the Journal of the American Heart Association.

Statin, antiplatelet prescriptions lag for PAD patients at risk of stroke

Heart patients with symptoms of peripheral artery disease (PAD) continue to see low rates of prescriptions for antiplatelets, statins and ACE inhibitors, despite those drugs’ potential to prevent against major events like stroke, according to research published Nov. 15 in Stroke.

Severe migraines could signal elevated risk for AFib, stroke

A decades-long study of patients who have migraines with visual aura has linked the painful headaches to an increased risk of experiencing atrial fibrillation and, to a lesser degree, stroke, researchers report in the online edition of Neurology.

Algorithm leans on patient-reported variables to predict mortality

A machine learning algorithm that predicts five-year mortality among patients with atherosclerotic cardiovascular disease (ASCVD) makes the case that patient responses to questionnaires can be just as informative in risk stratification as clinical characteristics and lab measurements.

How Snapchat saved a stroke patient’s life with 12 minutes to spare

Social media app Snapchat has been credited with saving 39-year-old Darnisha Ladd’s life after a recorded video helped physicians diagnose the young stroke survivor, allowing them to administer life-saving medication with 12 minutes to spare, the Omaha World-Herald has reported.

DOACs cut dementia risk in AFib patients more than warfarin

For patients with nonvalvular atrial fibrillation (AFib), taking a direct oral anticoagulant (DOAC) instead of warfarin may cut the risk of dementia by 15 to 20 percent, according to a large database study published Nov. 2 in the Journal of the American Heart Association.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall